Mesa Laboratories (MLAB) Income from Continuing Operations (2010 - 2026)
Mesa Laboratories' (MLAB) quarterly Income from Continuing Operations came in at $2.8 million in Q2 2026, down 40.32% year-over-year from $4.7 million in Q2 2025, and up 152.24% quarter-over-quarter from -$5.4 million in Q1 2026.
Analysis
Mesa Laboratories (MLAB) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Mesa Laboratories has disclosed Income from Continuing Operations across 17 years of filings, most recently posting $2.8 million for Q2 2026.
- In Q2 2026, Income from Continuing Operations fell 40.32% year-over-year to $2.8 million; the TTM figure through Jun 2026 stood at $3.5 million (up 616.74% YoY), while the FY2026 annual figure was $5.4 million, up 366.88% from the prior year.
- Income from Continuing Operations came in at $2.8 million for Q2 2026 at Mesa Laboratories, up from -$5.4 million in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of $4.7 million in Q2 2025 to a low of -$218.1 million in Q1 2024.
- Average Income from Continuing Operations over 5 years is -$12.0 million, with a median of -$49000.0 recorded in 2022.
- The largest YoY upside for Income from Continuing Operations was 717.12% in 2024 against a maximum downside of 7397.39% in 2024.
- Over 5 years, Income from Continuing Operations stood at $451000.0 in 2022, then surged by 369.18% to $2.1 million in 2023, then tumbled by 179.21% to -$1.7 million in 2024, then jumped by 316.59% to $3.6 million in 2025, then fell by 22.04% to $2.8 million in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were $2.8 million in Q2 2026, -$5.4 million in Q1 2026, and $3.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn | 362.00 Mn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn | 207.00 Mn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn | 53.48 Mn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn | 54.62 Mn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn | 371.40 Mn |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn | 5.01 Mn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn | -17.93 Mn |
| 10 | Mesa Laboratories | 684.72 Mn | 652.49 Mn | 39.01 Mn | 2.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.83 Mn |
| Mar 31, 2026 | -5.42 Mn |
| Dec 31, 2025 | 3.63 Mn |
| Sep 30, 2025 | 2.48 Mn |
| Jun 30, 2025 | 4.74 Mn |
| Mar 31, 2025 | -7.18 Mn |
| Dec 31, 2024 | -1.68 Mn |
| Sep 30, 2024 | 3.43 Mn |
| Jun 30, 2024 | 3.39 Mn |
| Mar 31, 2024 | -218.10 Mn |
| Dec 31, 2023 | 2.12 Mn |
| Sep 30, 2023 | -1.78 Mn |
| Jun 30, 2023 | -549,000.00 |
| Mar 31, 2023 | -2.91 Mn |
| Dec 31, 2022 | 451,000.00 |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | -1.44 Mn |
| Mar 31, 2022 | -1.78 Mn |
| Dec 31, 2021 | -2.06 Mn |
| Sep 30, 2021 | 3.72 Mn |